The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure

被引：0
|
作者：
Shah, KB
Rao, K
Sawyer, R
Gottlieb, SS
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[2] Baltimore Vet Affiars Med Ctr, Baltimore, MD USA
来源：
JOURNAL OF CARDIAC FAILURE | 2005年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
032
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [1] The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure
    Shah, KB
    Rao, K
    Sawyer, R
    Gottlieb, SS
    CIRCULATION, 2005, 112 (17) : U408 - U408
  • [2] The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure
    Shah, KB
    Rao, K
    Sawyer, R
    Gottlieb, SS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) : 845 - 849
  • [3] Spironolactone in congestive heart failure
    Soberman J.E.
    Weber K.T.
    Current Hypertension Reports, 2000, 2 (5) : 451 - 456
  • [4] Spironolactone and congestive heart-failure
    Georges, B
    Beguin, C
    Jadoul, M
    LANCET, 2000, 355 (9212): : 1369 - 1370
  • [5] Spironolactone in the treatment of congestive heart failure
    Lloyd, SJ
    Mauro, VF
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (11) : 1336 - 1340
  • [6] Use of Spironolactone in the Treatment of Congestive Heart Failure
    Jean, Lachaine
    Catherine, Beauchemin
    Elodie, Ramos
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S132 - S132
  • [7] SPIRONOLACTONE IN THE MANAGEMENT OF CONGESTIVE HEART-FAILURE
    MULLER, JE
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (23): : K51 - K53
  • [8] Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure
    Tsutamoto, T
    Wada, A
    Maeda, K
    Mabuchi, N
    Hayashi, M
    Tsutsui, T
    Ohnishi, M
    Sawaki, M
    Fujii, M
    Matsumoto, T
    Horie, H
    Sugimoto, Y
    Kinoshita, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 838 - 844
  • [9] CAPTOPRIL AND SPIRONOLACTONE THERAPY IN PATIENTS WITH REFRACTORY CONGESTIVE-HEART-FAILURE
    DAHLSTROM, U
    KARLSSON, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (02): : 235 - 248
  • [10] The effects of spironolactone and metoprolol on QT dispersion in patients with congestive heart failure
    Akbulut, M
    Karaca, I
    Ilkay, E
    Özbay, Y
    Arslan, N
    ADVANCES IN CORONARY ARTERY DISEASE, 2001, : 561 - 566
12345